nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—kidney cancer	0.865	1	CbGaD
Etomidate—CYP19A1—Paclitaxel—kidney cancer	0.0101	1	CbGbCtD
Etomidate—Pseudoephedrine—IL2—kidney cancer	0.00134	0.352	CrCbGaD
Etomidate—Ephedrine—ACHE—kidney cancer	0.00104	0.274	CrCbGaD
Etomidate—Hiccups—Pazopanib—kidney cancer	0.000815	0.0498	CcSEcCtD
Etomidate—Myoclonus—Vincristine—kidney cancer	0.000756	0.0461	CcSEcCtD
Etomidate—Hypoxia—Gemcitabine—kidney cancer	0.000679	0.0414	CcSEcCtD
Etomidate—Ephedrine—BCHE—kidney cancer	0.000613	0.161	CrCbGaD
Etomidate—Respiratory failure—Sunitinib—kidney cancer	0.000547	0.0334	CcSEcCtD
Etomidate—Fenoprofen—PTGS1—kidney cancer	0.000514	0.135	CrCbGaD
Etomidate—Myoclonus—Capecitabine—kidney cancer	0.000493	0.0301	CcSEcCtD
Etomidate—Respiratory failure—Vincristine—kidney cancer	0.000463	0.0283	CcSEcCtD
Etomidate—Respiratory failure—Gemcitabine—kidney cancer	0.000439	0.0268	CcSEcCtD
Etomidate—Bradycardia—Pazopanib—kidney cancer	0.000417	0.0254	CcSEcCtD
Etomidate—Respiratory failure—Paclitaxel—kidney cancer	0.000368	0.0224	CcSEcCtD
Etomidate—Convulsion—Temsirolimus—kidney cancer	0.000328	0.02	CcSEcCtD
Etomidate—Hypertension—Temsirolimus—kidney cancer	0.000327	0.0199	CcSEcCtD
Etomidate—Hypertension—Pazopanib—kidney cancer	0.000308	0.0188	CcSEcCtD
Etomidate—Hiccups—Capecitabine—kidney cancer	0.000296	0.0181	CcSEcCtD
Etomidate—Fenoprofen—PTGS2—kidney cancer	0.000294	0.0774	CrCbGaD
Etomidate—Arrhythmia—Erlotinib—kidney cancer	0.000279	0.017	CcSEcCtD
Etomidate—Hyperventilation—Doxorubicin—kidney cancer	0.000278	0.0169	CcSEcCtD
Etomidate—Bradycardia—Sunitinib—kidney cancer	0.000275	0.0168	CcSEcCtD
Etomidate—Pain—Temsirolimus—kidney cancer	0.000264	0.0161	CcSEcCtD
Etomidate—Arrhythmia—Sorafenib—kidney cancer	0.000251	0.0153	CcSEcCtD
Etomidate—Pain—Pazopanib—kidney cancer	0.000249	0.0152	CcSEcCtD
Etomidate—Convulsion—Vinblastine—kidney cancer	0.000245	0.0149	CcSEcCtD
Etomidate—Hypertension—Vinblastine—kidney cancer	0.000244	0.0149	CcSEcCtD
Etomidate—Convulsion—Everolimus—kidney cancer	0.000244	0.0149	CcSEcCtD
Etomidate—Hypertension—Everolimus—kidney cancer	0.000243	0.0148	CcSEcCtD
Etomidate—Arrhythmia—Sunitinib—kidney cancer	0.000241	0.0147	CcSEcCtD
Etomidate—Tachycardia—Everolimus—kidney cancer	0.000224	0.0137	CcSEcCtD
Etomidate—Hypotension—Everolimus—kidney cancer	0.000215	0.0131	CcSEcCtD
Etomidate—Hypertension—Sorafenib—kidney cancer	0.000211	0.0129	CcSEcCtD
Etomidate—Convulsion—Sunitinib—kidney cancer	0.000204	0.0124	CcSEcCtD
Etomidate—Hypertension—Sunitinib—kidney cancer	0.000203	0.0124	CcSEcCtD
Etomidate—Pain—Vinblastine—kidney cancer	0.000197	0.012	CcSEcCtD
Etomidate—Pain—Everolimus—kidney cancer	0.000196	0.012	CcSEcCtD
Etomidate—Vomiting—Temsirolimus—kidney cancer	0.000196	0.012	CcSEcCtD
Etomidate—Arrhythmia—Gemcitabine—kidney cancer	0.000194	0.0118	CcSEcCtD
Etomidate—Hiccups—Doxorubicin—kidney cancer	0.000191	0.0117	CcSEcCtD
Etomidate—Pain—Erlotinib—kidney cancer	0.000189	0.0116	CcSEcCtD
Etomidate—Vomiting—Pazopanib—kidney cancer	0.000185	0.0113	CcSEcCtD
Etomidate—Bradycardia—Paclitaxel—kidney cancer	0.000185	0.0113	CcSEcCtD
Etomidate—Convulsion—Vincristine—kidney cancer	0.000172	0.0105	CcSEcCtD
Etomidate—Hypertension—Vincristine—kidney cancer	0.000172	0.0105	CcSEcCtD
Etomidate—Pain—Sorafenib—kidney cancer	0.00017	0.0104	CcSEcCtD
Etomidate—Pain—Sunitinib—kidney cancer	0.000164	0.01	CcSEcCtD
Etomidate—Hypertension—Gemcitabine—kidney cancer	0.000163	0.00994	CcSEcCtD
Etomidate—Arrhythmia—Paclitaxel—kidney cancer	0.000162	0.00989	CcSEcCtD
Etomidate—Pain—Dactinomycin—kidney cancer	0.000155	0.00948	CcSEcCtD
Etomidate—Hypotension—Vincristine—kidney cancer	0.000152	0.00925	CcSEcCtD
Etomidate—Bradycardia—Capecitabine—kidney cancer	0.000152	0.00925	CcSEcCtD
Etomidate—Vomiting—Vinblastine—kidney cancer	0.000147	0.00895	CcSEcCtD
Etomidate—Vomiting—Everolimus—kidney cancer	0.000146	0.00891	CcSEcCtD
Etomidate—Hypotension—Gemcitabine—kidney cancer	0.000144	0.00878	CcSEcCtD
Etomidate—Vomiting—Erlotinib—kidney cancer	0.000141	0.0086	CcSEcCtD
Etomidate—Pain—Vincristine—kidney cancer	0.000139	0.00847	CcSEcCtD
Etomidate—Convulsion—Paclitaxel—kidney cancer	0.000137	0.00835	CcSEcCtD
Etomidate—Hypertension—Paclitaxel—kidney cancer	0.000136	0.00832	CcSEcCtD
Etomidate—Arrhythmia—Capecitabine—kidney cancer	0.000133	0.00812	CcSEcCtD
Etomidate—Pain—Gemcitabine—kidney cancer	0.000132	0.00803	CcSEcCtD
Etomidate—Vomiting—Sorafenib—kidney cancer	0.000127	0.00774	CcSEcCtD
Etomidate—Tachycardia—Paclitaxel—kidney cancer	0.000126	0.00768	CcSEcCtD
Etomidate—Vomiting—Sunitinib—kidney cancer	0.000122	0.00744	CcSEcCtD
Etomidate—Hypotension—Paclitaxel—kidney cancer	0.00012	0.00735	CcSEcCtD
Etomidate—Vomiting—Dactinomycin—kidney cancer	0.000115	0.00705	CcSEcCtD
Etomidate—Hypertension—Capecitabine—kidney cancer	0.000112	0.00683	CcSEcCtD
Etomidate—Pain—Paclitaxel—kidney cancer	0.00011	0.00673	CcSEcCtD
Etomidate—Tachycardia—Capecitabine—kidney cancer	0.000103	0.0063	CcSEcCtD
Etomidate—Vomiting—Vincristine—kidney cancer	0.000103	0.0063	CcSEcCtD
Etomidate—Hypotension—Capecitabine—kidney cancer	9.88e-05	0.00603	CcSEcCtD
Etomidate—Vomiting—Gemcitabine—kidney cancer	9.79e-05	0.00597	CcSEcCtD
Etomidate—Bradycardia—Doxorubicin—kidney cancer	9.77e-05	0.00596	CcSEcCtD
Etomidate—Pain—Capecitabine—kidney cancer	9.04e-05	0.00552	CcSEcCtD
Etomidate—Arrhythmia—Doxorubicin—kidney cancer	8.57e-05	0.00523	CcSEcCtD
Etomidate—Vomiting—Paclitaxel—kidney cancer	8.19e-05	0.005	CcSEcCtD
Etomidate—Convulsion—Doxorubicin—kidney cancer	7.24e-05	0.00442	CcSEcCtD
Etomidate—Hypertension—Doxorubicin—kidney cancer	7.21e-05	0.0044	CcSEcCtD
Etomidate—Vomiting—Capecitabine—kidney cancer	6.72e-05	0.0041	CcSEcCtD
Etomidate—Tachycardia—Doxorubicin—kidney cancer	6.65e-05	0.00406	CcSEcCtD
Etomidate—Hypotension—Doxorubicin—kidney cancer	6.37e-05	0.00389	CcSEcCtD
Etomidate—Pain—Doxorubicin—kidney cancer	5.83e-05	0.00356	CcSEcCtD
Etomidate—SLC2A1—Metabolism—GSTP1—kidney cancer	5.67e-05	0.000542	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—RAF1—kidney cancer	5.62e-05	0.000537	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.53e-05	0.000529	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PDHB—kidney cancer	5.52e-05	0.000527	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—POMC—kidney cancer	5.5e-05	0.000526	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GRB7—kidney cancer	5.49e-05	0.000525	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCB1—kidney cancer	5.37e-05	0.000513	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HIF1A—kidney cancer	5.24e-05	0.000501	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TSC2—kidney cancer	5.23e-05	0.0005	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTM1—kidney cancer	5.21e-05	0.000498	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	5.2e-05	0.000497	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CCBL1—kidney cancer	5.19e-05	0.000496	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—RAF1—kidney cancer	5.14e-05	0.000491	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA9—kidney cancer	5.11e-05	0.000489	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITPR2—kidney cancer	5.1e-05	0.000488	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	5.05e-05	0.000483	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CRABP1—kidney cancer	5.05e-05	0.000482	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5e-05	0.000478	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1A1—kidney cancer	4.94e-05	0.000472	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	4.91e-05	0.00047	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OR4C13—kidney cancer	4.9e-05	0.000468	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ANXA1—kidney cancer	4.78e-05	0.000457	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	4.75e-05	0.000454	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ITPR2—kidney cancer	4.69e-05	0.000449	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.69e-05	0.000449	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APC—kidney cancer	4.62e-05	0.000442	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KIT—kidney cancer	4.62e-05	0.000442	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	4.55e-05	0.000435	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.53e-05	0.000434	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GLIPR1—kidney cancer	4.5e-05	0.00043	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPAT—kidney cancer	4.5e-05	0.00043	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—RAF1—kidney cancer	4.49e-05	0.00043	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.44e-05	0.000425	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	4.4e-05	0.000421	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.4e-05	0.00042	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	4.39e-05	0.00042	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.38e-05	0.000419	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—BRAF—kidney cancer	4.36e-05	0.000417	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	4.36e-05	0.000416	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CRABP1—kidney cancer	4.35e-05	0.000416	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	4.34e-05	0.000415	CbGpPWpGaD
Etomidate—SLC2A1—Disease—BRAF—kidney cancer	4.34e-05	0.000415	CbGpPWpGaD
Etomidate—Vomiting—Doxorubicin—kidney cancer	4.33e-05	0.00265	CcSEcCtD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.33e-05	0.000414	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.33e-05	0.000413	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—kidney cancer	4.28e-05	0.000409	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ACHE—kidney cancer	4.28e-05	0.000409	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	4.25e-05	0.000406	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APRT—kidney cancer	4.18e-05	0.0004	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—FH—kidney cancer	4.18e-05	0.0004	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LATS1—kidney cancer	4.17e-05	0.000398	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.15e-05	0.000396	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.09e-05	0.000391	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SCARB1—kidney cancer	4.05e-05	0.000387	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ITPR2—kidney cancer	4.04e-05	0.000387	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	4.04e-05	0.000386	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS1—kidney cancer	4.01e-05	0.000383	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.01e-05	0.000383	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.01e-05	0.000383	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—BRAF—kidney cancer	3.99e-05	0.000381	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	3.96e-05	0.000379	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPC3—kidney cancer	3.93e-05	0.000376	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PSMD7—kidney cancer	3.93e-05	0.000376	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—kidney cancer	3.87e-05	0.00037	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	3.84e-05	0.000367	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA2—kidney cancer	3.82e-05	0.000366	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	3.8e-05	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKAP13—kidney cancer	3.79e-05	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA1—kidney cancer	3.74e-05	0.000358	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.73e-05	0.000356	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BCHE—kidney cancer	3.73e-05	0.000356	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALAD—kidney cancer	3.73e-05	0.000356	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ACHE—kidney cancer	3.69e-05	0.000352	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—kidney cancer	3.69e-05	0.000352	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—kidney cancer	3.68e-05	0.000352	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC5A5—kidney cancer	3.68e-05	0.000352	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—RAF1—kidney cancer	3.64e-05	0.000348	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ST3GAL2—kidney cancer	3.64e-05	0.000348	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RAF1—kidney cancer	3.63e-05	0.000347	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.63e-05	0.000347	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—kidney cancer	3.59e-05	0.000343	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALDH1A1—kidney cancer	3.56e-05	0.00034	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC2A1—kidney cancer	3.56e-05	0.00034	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AMER1—kidney cancer	3.54e-05	0.000339	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTOR—kidney cancer	3.54e-05	0.000338	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD4—kidney cancer	3.53e-05	0.000338	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.53e-05	0.000337	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	3.53e-05	0.000337	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—kidney cancer	3.51e-05	0.000335	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.5e-05	0.000335	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SCARB1—kidney cancer	3.49e-05	0.000334	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA2—kidney cancer	3.49e-05	0.000333	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—BRAF—kidney cancer	3.48e-05	0.000333	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS1—kidney cancer	3.46e-05	0.00033	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	3.45e-05	0.00033	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.45e-05	0.00033	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKAP13—kidney cancer	3.44e-05	0.000329	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PGK1—kidney cancer	3.41e-05	0.000326	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC5A3—kidney cancer	3.41e-05	0.000326	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PSMD7—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.35e-05	0.00032	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LDHB—kidney cancer	3.34e-05	0.00032	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—RAF1—kidney cancer	3.33e-05	0.000318	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1B—kidney cancer	3.32e-05	0.000318	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	3.26e-05	0.000312	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.26e-05	0.000311	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ITPR2—kidney cancer	3.22e-05	0.000308	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BCHE—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC5A5—kidney cancer	3.17e-05	0.000303	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.16e-05	0.000302	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CTNNB1—kidney cancer	3.14e-05	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—kidney cancer	3.14e-05	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.08e-05	0.000294	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC2A1—kidney cancer	3.06e-05	0.000293	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTEN—kidney cancer	3.06e-05	0.000292	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.01e-05	0.000288	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—kidney cancer	3e-05	0.000287	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.98e-05	0.000285	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CER1—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GPC3—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ITPR2—kidney cancer	2.93e-05	0.00028	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—RAF1—kidney cancer	2.91e-05	0.000278	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA9—kidney cancer	2.9e-05	0.000277	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	2.9e-05	0.000277	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.83e-05	0.000271	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—kidney cancer	2.81e-05	0.000268	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.76e-05	0.000264	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—kidney cancer	2.73e-05	0.000261	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ANXA1—kidney cancer	2.7e-05	0.000258	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK3—kidney cancer	2.61e-05	0.00025	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.6e-05	0.000249	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.59e-05	0.000248	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1A1—kidney cancer	2.58e-05	0.000247	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—kidney cancer	2.56e-05	0.000245	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—kidney cancer	2.56e-05	0.000244	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.55e-05	0.000244	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—kidney cancer	2.54e-05	0.000243	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SFRP2—kidney cancer	2.52e-05	0.000241	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAPK1—kidney cancer	2.5e-05	0.000239	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK1—kidney cancer	2.49e-05	0.000238	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CRABP1—kidney cancer	2.46e-05	0.000236	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ANXA1—kidney cancer	2.45e-05	0.000235	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—kidney cancer	2.42e-05	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.42e-05	0.000231	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KRAS—kidney cancer	2.35e-05	0.000225	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—kidney cancer	2.35e-05	0.000225	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—kidney cancer	2.34e-05	0.000224	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.3e-05	0.00022	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ITPR2—kidney cancer	2.29e-05	0.000219	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAPK1—kidney cancer	2.28e-05	0.000218	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1A1—kidney cancer	2.23e-05	0.000213	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—kidney cancer	2.16e-05	0.000206	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.12e-05	0.000203	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.11e-05	0.000202	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—kidney cancer	2.09e-05	0.0002	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ACHE—kidney cancer	2.09e-05	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP2—kidney cancer	2.03e-05	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKAP13—kidney cancer	2.03e-05	0.000194	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MAPK1—kidney cancer	2e-05	0.000191	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.99e-05	0.000191	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SCARB1—kidney cancer	1.98e-05	0.000189	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS1—kidney cancer	1.96e-05	0.000187	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.96e-05	0.000187	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—kidney cancer	1.93e-05	0.000184	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PSMD7—kidney cancer	1.92e-05	0.000184	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRB7—kidney cancer	1.86e-05	0.000178	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.83e-05	0.000175	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCHE—kidney cancer	1.82e-05	0.000174	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—kidney cancer	1.81e-05	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC5A5—kidney cancer	1.8e-05	0.000172	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.79e-05	0.000171	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC2A1—kidney cancer	1.74e-05	0.000166	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITPR2—kidney cancer	1.73e-05	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RAF1—kidney cancer	1.73e-05	0.000165	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.68e-05	0.000161	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNA1—kidney cancer	1.57e-05	0.00015	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.56e-05	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EIF4EBP1—kidney cancer	1.56e-05	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HSPB1—kidney cancer	1.56e-05	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—kidney cancer	1.55e-05	0.000148	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—kidney cancer	1.54e-05	0.000147	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.47e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PSMD7—kidney cancer	1.45e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC1—kidney cancer	1.45e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ANXA1—kidney cancer	1.45e-05	0.000139	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—kidney cancer	1.45e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FLT1—kidney cancer	1.4e-05	0.000134	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—kidney cancer	1.37e-05	0.000131	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—kidney cancer	1.34e-05	0.000128	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—kidney cancer	1.33e-05	0.000127	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—kidney cancer	1.32e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JUNB—kidney cancer	1.3e-05	0.000124	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PAK1—kidney cancer	1.3e-05	0.000124	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A1—kidney cancer	1.26e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK3—kidney cancer	1.24e-05	0.000119	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—kidney cancer	1.2e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK1—kidney cancer	1.18e-05	0.000113	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—kidney cancer	1.15e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KRAS—kidney cancer	1.12e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—kidney cancer	1.06e-05	0.000102	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN2B—kidney cancer	1.06e-05	0.000101	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1R—kidney cancer	1.03e-05	9.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—kidney cancer	1.03e-05	9.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—kidney cancer	9.94e-06	9.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RAF1—kidney cancer	9.91e-06	9.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—kidney cancer	9.79e-06	9.36e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—kidney cancer	9.45e-06	9.04e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—kidney cancer	9.41e-06	8.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—kidney cancer	8.89e-06	8.5e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—kidney cancer	8.47e-06	8.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC2—kidney cancer	8.45e-06	8.08e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—kidney cancer	8.15e-06	7.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—kidney cancer	8.1e-06	7.74e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—kidney cancer	7.5e-06	7.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KIT—kidney cancer	7.46e-06	7.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—kidney cancer	7.46e-06	7.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK3—kidney cancer	7.14e-06	6.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—kidney cancer	7.1e-06	6.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BRAF—kidney cancer	7.01e-06	6.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK1—kidney cancer	6.8e-06	6.5e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—kidney cancer	6.54e-06	6.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—kidney cancer	6.5e-06	6.21e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—kidney cancer	6.42e-06	6.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—kidney cancer	5.9e-06	5.64e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAF1—kidney cancer	5.86e-06	5.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RELA—kidney cancer	5.83e-06	5.57e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—kidney cancer	5.79e-06	5.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MTOR—kidney cancer	5.72e-06	5.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	5.36e-06	5.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—kidney cancer	5.25e-06	5.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—kidney cancer	5.12e-06	4.89e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JUN—kidney cancer	5.11e-06	4.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	5.07e-06	4.85e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.94e-06	4.72e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—kidney cancer	4.62e-06	4.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	4.46e-06	4.27e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	4.22e-06	4.03e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—kidney cancer	4.11e-06	3.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	4.02e-06	3.84e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.79e-06	3.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.48e-06	3.33e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—kidney cancer	3.37e-06	3.22e-05	CbGpPWpGaD
